Oppenheimer Positive on Endologix (ELGX) After Meeting with Management; Very Impressive Pipeline
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Rating Summary:
7 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
7 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
Oppenheimer maintains an 'Outperform' on Endologix (NASDAQ: ELGX) price target of $17.00.
Analyst, Steven Lichtman, said, "We recently hosted meetings with ELGX management and came away confident that this growth story remains very much in tact: Abdominal aortic aneurysm (AAA) market volumes/pricing remain solid, ELGX's sales force is gaining in strength and the company's competition trails in the development of pipeline products to rival Nellix or Ventana. Moreover, we believe the Street is still underestimating Nellix’s potential in mainstream AAA. All told, we forecast >25% sales growth over the next five years. We remain buyers ahead of several 2H pipeline catalysts including approvals of Nellix (EU), PEVAR (US), Intuitrak (Japan) and Ventana (EU)."
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $14.33 yesterday.
Analyst, Steven Lichtman, said, "We recently hosted meetings with ELGX management and came away confident that this growth story remains very much in tact: Abdominal aortic aneurysm (AAA) market volumes/pricing remain solid, ELGX's sales force is gaining in strength and the company's competition trails in the development of pipeline products to rival Nellix or Ventana. Moreover, we believe the Street is still underestimating Nellix’s potential in mainstream AAA. All told, we forecast >25% sales growth over the next five years. We remain buyers ahead of several 2H pipeline catalysts including approvals of Nellix (EU), PEVAR (US), Intuitrak (Japan) and Ventana (EU)."
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $14.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
- Jefferies Starts Aditya Birla Real Estate (ABREL:IN) at Buy
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
